BGC > Produktsuche > Laropiprant | 571170-77-9

Molecular Formula: C21H19ClFNO4S
Molecular Weight: 435.901

Description:
a drug used in combination with niacin to reduce blood cholesterol (LDL and VLDL) that is no longer sold

• Molecular Weight:435.91
• Melting Point:175°C
• Purity:> 95%

Molecular Formula:
C21H19ClFNO4S
Canonical SMILES:
CS(=O)(=O)C1=C2C(=CC(=C1)F)C3=C(N2CC4=CC=C(C=C4)Cl)C(CC3)CC(=O)O
InChI:
1S/C21H19ClFNO4S/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26)/t13-/m1/s1
InChIKey:
NXFFJDQHYLNEJK-CYBMUJFWSA-N
Solubility:
Soluble in DMSO
Appearance:
A crystalline solid
Application:
A potent, selective DP1 receptor antagonist
Storage: Store at -20 °C
Synonyms:
(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-cyclopent[b]indole-3-acetic acid